Fierce Healthcare

NOVEMBER 24, 2021

HHS warns of increasing zero-day attacks in healthcare. rtorrence. Wed, 11/24/2021 - 11:05.

145

145

pharmaphorum

NOVEMBER 25, 2021

A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears it could be resistant to the effect of currently-used vaccines. The B.1.1.529 variant has more mutations affecting the spike protein targeted by vaccines than any other strain identified to date, although it’s not yet clear if it is more or less transmissible.

Vaccines 116

Vaccines Immunization 116

Outsourcing Pharma

NOVEMBER 25, 2021

A new clinical trial of heterologous â or âmix-and-matchâ â combinations of COVID-19 vaccines is set to start in Pakistan: seeking to add to research on the effectiveness of such combinations.

Vaccines 111

Vaccines 111

Fossil Remedies

NOVEMBER 26, 2021

Monopoly PCD Pharma franchise model is a specialized business model where the company provides franchises on a monopoly basis all over the country for marketing and distribution of products. Why does this business model hold a unique place in the business space? In fact, it is the most prevalent model. The reason is it I profitable and appealing. All leading and successful companies give it precedence.

Documentation 88

Documentation 88

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

NOVEMBER 23, 2021

Epic's sepsis algorithm may have caused alert fatigue with 43% alert increase during pandemic. rtorrence. Tue, 11/23/2021 - 12:45.

141

141

pharmaphorum

NOVEMBER 25, 2021

Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, finds new PhRMA report. For too many Americans, insurance coverage is not providing the health security it’s meant to. The Pharmaceutical Research and Manufacturers of America’s (PhRMA) first Patient Experience Survey (PES) has found that three in ten people with medical insurance still face financial barriers to accessing healthcare and prescription medicines.

Insurance 116

Insurance Insurance Coverage 116

Pharma Times

NOVEMBER 25, 2021

A team of scientists and pharmaceutical collaborators have discovered a ‘bench to bedside’ drug design, which will hopefully improve the future treatment of Alzheimer’s disease.

70

70

Fierce Healthcare

NOVEMBER 24, 2021

UnitedHealth Group taps Wilson as new chief medical officer. hlandi. Wed, 11/24/2021 - 12:10.

132

132

pharmaphorum

NOVEMBER 23, 2021

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for whole genome sequencing (WGS) has reached a level at which its national rollout on the NHS may someday become a reality. The timing of this announcement is particularly opportune, as increasing knowledge and advances in WGS amongst scientists has resulted in the technology becoming increasingly affordable and effective, making its incorporation into the existing standardis

Hospitals 116

Hospitals Clinic Management 116

Outsourcing Pharma

NOVEMBER 22, 2021

The US agency has granted approval to Voxzogo, an injectable drug designed to aid growth in children with achondroplasia, the most common form of dwarfism.

FDA 104

FDA 104

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

NOVEMBER 22, 2021

The oral antiviral drug is for the treatment of patients with COVID-19

58

58

Fierce Healthcare

NOVEMBER 21, 2021

Two private equity firms near $17B deal to acquire Athenahealth: WSJ report. hlandi. Sun, 11/21/2021 - 21:34.

131

131

pharmaphorum

NOVEMBER 22, 2021

Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California’s Institute for Creative Technologies (USC ICT), tells us how its virtual reality (VR) therapy BRAVEMIND is changing PTSD treatment and how pharma can leverage clinical VR. “There’s a strong evidence base for VR applications in many areas, but it’s also breaking down barriers to care.

Pharmaceutical Companies 116

Pharmaceutical Companies Pharmaceutical Companies FDA 116

Outsourcing Pharma

NOVEMBER 22, 2021

The StudyTeam Diversity Reporting feature is intended to aid sites and sponsors measure their efforts to reach patients from underrepresented communities.

96

96

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

NOVEMBER 24, 2021

With the latest approval from the EC, patients in Europe suffering from metastatic triple-negative breast cancer can now receive Gilead Science’s Trodlevy as part of their treatment.

58

58

Fierce Healthcare

NOVEMBER 23, 2021

Federal jury holds pharmacy chains CVS, Walgreens and Walmart responsible for role in opioid crisis. hlandi. Tue, 11/23/2021 - 17:09.

128

128

pharmaphorum

NOVEMBER 24, 2021

Takeda has scored the first-ever FDA approval of a treatment for refractory cytomegalovirus (CMV) infections in organ transplant patients, which can lead to an increased risk of complications and even death. Livtencity (maribavir) has been cleared for use in transplant patients aged 12 or over with CMV infections that do not respond to first-line treatment with current antiviral drugs for CMV, such as ganciclovir, valganciclovir, foscarnet and cidofovir.

FDA 105

FDA 105

Outsourcing Pharma

NOVEMBER 23, 2021

AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.

72

72

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

NOVEMBER 22, 2021

The approval of Covaxin follows the WHO Emergency Use Listing for the vaccine

Vaccines 57

Vaccines 57

Fierce Healthcare

NOVEMBER 22, 2021

Industry Voices—Health plans look to HIEs while expanding population health work. hlandi. Mon, 11/22/2021 - 20:23.

126

126

pharmaphorum

NOVEMBER 23, 2021

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge, said to be the biggest science lab of its kind in the UK. The Discovery Centre (DISC) based in the Cambridge Biomedical Campus – first given the green light in 2015 – is being officially opened today by Prince Charles. It can accommodate more than 2,200 research scientists, has 19,000 square metres of lab space, and boasts “the most advanced robotics, high-throughput scre

Hospitals 105

Hospitals 105

Outsourcing Pharma

NOVEMBER 23, 2021

Leaders from the trial tech provider discuss how human-focused technology on eClinical platforms can tackle inefficiencies associated with traditional studies.

59

59

Pharma Times

NOVEMBER 26, 2021

The Food and Drug Administration (FDA) granted approval for emergency use of the Comirnaty vaccine in children in October 2021.

Vaccines 56

Vaccines FDA 56

Fierce Healthcare

NOVEMBER 22, 2021

Digital MSK provider Sword Health gets $189M, boosts valuation to $1.8B. rtorrence. Mon, 11/22/2021 - 11:33.

123

123

pharmaphorum

NOVEMBER 23, 2021

Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company. The French drugmaker has been enticed by an artificial intelligence (AI) algorithm developed by Chinese tech giant Baidu, which controls most of China’s search engine traffic and is sometimes referred to as the country’s Google.

Vaccines 105

Vaccines Immunization 105

Pharma Mirror

NOVEMBER 26, 2021

In recent years, it has become more and more important to both consumers and investors that they support organisations which display a high level of social and environmental responsibility. This means that it’s no longer enough for businesses to manage their bottom lines and maintain profitability, they must also be conscious of the impact they have on the world around them.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Times

NOVEMBER 26, 2021

Data from the UK’s Health Security Agency (UKHSA) has revealed that COVID-19 vaccines are safe in pregnancy.

Vaccines 54

Vaccines 54

Fierce Healthcare

NOVEMBER 22, 2021

Survey: Majority of Medicaid managed care plans offered health equity benefits in 2020. rking. Mon, 11/22/2021 - 14:40.

123

123

pharmaphorum

NOVEMBER 23, 2021

A year ago, Swiss biotech Santhera was slashing staff to cut costs after it abandoned lead Duchenne muscular dystrophy (DMD) therapy idebenone. Now, it’s ready to file replacement drug vamorolone, armed with new data from a pivotal trial, in what looks like a reversal of its fortunes. With prospects for idebenone looking shaky, Santhera snapped up vamorolone from US biotech ReveraGen BioPharma in August 2020 , claiming worldwide rights to the nonhormonal steroid modulator in DMD and all ot

Immunization 104

Immunization FDA 104

Pharma Mirror

NOVEMBER 25, 2021

Terrassa (Barcelona) Telstar launches a new global service platform for retrofitting and maintenance of existing freeze-dryers, regardless of brand and model. Under Usifroid brand, this platform is specialized in providing a retrofitting and modernization service together with maintenance services and technical support to freeze-drying equipment for pharmaceutical production and research.

FDA 52

FDA 52

Pharma Times

NOVEMBER 26, 2021

After hosting a virtual ceremony in 2020, this year’s awards returned to the Royal Lancaster London hotel

54

54

Fierce Healthcare

NOVEMBER 24, 2021

Massachusetts calls on hospitals to reduce elective procedures amid staffing shortages. rking. Wed, 11/24/2021 - 12:35.

Hospitals 121

Hospitals 121

pharmaphorum

NOVEMBER 26, 2021

Turkey could have its own COVID-19 vaccine Turkovac available for use by the end of the year, according to the country’s Health Minister Fahrettin Koca. An emergency use authorisation (EUA) application for the inactivated SARS-CoV-2 vaccine has been submitted to the Turkish Medicines and Medical Devices Agency (TITCK) on the back of preliminary data from ongoing phase 3 trials.

Vaccines 98

Vaccines 98